Glecaprevir and Pibrentasvir
- Generic Name
- Glecaprevir and Pibrentasvir
Overview
No overview information available.
Background
No background information available.
Indication
用于治疗全部6种基因型（GT1-6）慢性丙型肝炎病毒（HCV）成人患者，该药主要面向尚未出现肝硬化的HCV患者，以及HCV初治患者。此外，对于患有代偿性肝硬化或者治疗选择受限（如慢性肾病）的HCV患者，该复方药物同样适用。 不需要额外使用利巴韦林，就能起到泛基因型的丙肝治疗效果。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Product Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval Number |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval Number | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
H20190035 | 片剂 | 艾诺全 | 每片含格卡瑞韦100mg和哌仑他韦40mg | Chemical Drug | Approved | 2019/05/15 | Import |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Registration Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Registration Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath